FluorouracilAntimetabolitesAntimetabolites, AntineoplasticSurgical SpongesThioguanineLeucovorinMethotrexate6-MercaptopurineAntineoplastic Combined Chemotherapy ProtocolsVidarabine PhosphateTetrahydrouridine6-AminonicotinamideThymidylate SynthaseDeoxycytidineTrabeculectomyFloxuridineMitomycinPantothenic AcidNorleucinePhosphonoacetic AcidDihydrouracil Dehydrogenase (NADP)CytarabineOrganoplatinum CompoundsLeukemia L1210Antineoplastic AgentsAzathioprineDrug Administration ScheduleDrug SynergismColorectal NeoplasmsGuanineCisplatinInfusions, IntravenousCamptothecinUracilTumor Cells, CulturedStreptomycesNeoplasmsChemotherapy, AdjuvantAdenocarcinomaEpirubicinFluorodeoxyuridylateCombined Modality TherapyColonic NeoplasmsTreatment OutcomeCyclophosphamideCell SurvivalTegafurCell DivisionSurvival AnalysisSemustineDisease-Free SurvivalStomach NeoplasmsDoxorubicinApoptosisRectal NeoplasmsLevamisoleNeoplasm MetastasisBreast NeoplasmsSurvival RateInfusions, Intra-ArterialStomatitisLiver NeoplasmsLevoleucovorinCell LineBromouracilAntidotesFlucytosineDose-Response Relationship, DrugChronotherapyTaxoidsCarcinoma, Squamous CellProdrugsHead and Neck NeoplasmsEsophageal NeoplasmsPhosphoribosyl PyrophosphateLeukopeniaNeoplasm StagingMucositisDrug Resistance, NeoplasmNeutropeniaNeoadjuvant TherapyThymidine PhosphorylaseCytosine DeaminaseDrug EvaluationInjections, IntravenousPancreatic NeoplasmsOxonic AcidDihydropyrimidine Dehydrogenase DeficiencyNauseaNeoplasm Recurrence, LocalHepatic ArteryPaclitaxelDeoxyuracil NucleotidesUridineInterferon-alphaTrimetrexateUridine PhosphorylaseMaximum Tolerated DoseAdministration, OralMitomycins